C M Bidwell & Associates LTD Surface Oncology, Inc. Transaction History

C M Bidwell & Associates LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.62 - $1.21 $644 - $1,258	1,040 Added 139.6%	1,785 $1,000
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.1 $52,405 - $104,811	-49,910 Reduced 98.53%	745 $1,000
Q1 2022 Apr 29, 2022	BUY	$2.65 - $5.08 $45,394 - $87,020	17,130 Added 51.1%	50,655 $149,000
Q4 2021 Feb 11, 2022	BUY	$4.73 - $7.9 $2,341 - $3,910	495 Added 1.5%	33,525 $160,000
Q2 2021 Aug 13, 2021	BUY	$6.45 - $9.09 $104,425 - $147,167	16,190 Added 96.14%	33,030 $246,000
Q1 2021 May 14, 2021	BUY	$7.25 - $13.82 $122,090 - $232,728	16,840 New	16,840 $131,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.